SIU-ICUD: Epidemiology of Prostate Cancer
Société Internationale d’Urologie Journal · 12.06.2025 · 6 (3) · 44
DOI: 10.3390/siuj6030044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Société Internationale d’Urologie Journal, online erschienen am 12.06.2025. Verfasst von Bárbara Vieira Lima Aguiar Melão und 4 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health/National Cancer Institute, CAPES Foundation.
Abstract (Originalsprache)
Background/Objectives: Prostate cancer (PCa) is the second most common malignancy among men worldwide and a leading cause of cancer-related mortality. In 2022, over 1.4 million new cases were reported globally, with a prevalence exceeding 5 million. Despite its widespread occurrence, the incidence and mortality of PCa show substantial geographic variation, influenced by factors such as genetic predisposition, healthcare access, lifestyle, and the adoption of screening programs. Regions with high PCa incidence, such as Northern America and Oceania, often have lower mortality rates due to early detection and advanced healthcare infrastructure. Conversely, areas with limited access to medical resources, such as parts of Africa and Latin America, experience higher mortality rates.
Methods
This review explores non-modifiable risk factors such as age, family history, and race, emphasizing their role in PCa development and progression.
Results
Modifiable factors, including diet, physical activity, alcohol consumption, and smoking, are also addressed, with evidence suggesting their potential in mitigating risk. Emerging data on medications such as 5-alpha reductase inhibitors and statins, as well as dietary supplements such as vitamins D, indicate their potential for chemoprevention, though further research is needed to solidify these findings. Healthcare disparities, especially in low- and middle-income regions, highlight the need for equitable access to diagnostic tools and treatment options. The review underscores the significance of tailored screening approaches, particularly in high-risk populations, to optimize outcomes while minimizing overdiagnosis and overtreatment.
Conclusions
The review concludes with recommendations for future research, including the need for standardized screening protocols and the exploration of novel biomarkers for early detection. By synthesizing epidemiological data and current evidence, this review aims to enhance understanding of PCa risk factors, geographic disparities, and preventive strategies, ultimately contributing to improved global PCa management and outcomes.
Förderung
- National Institutes of Health/National Cancer Institute
- CAPES Foundation
Zitieren
APA
Melão, B. V. L. A., Pekala, K. R., Matsoukas, K., Bratt, O., & Carlsson, S. V. (2025). SIU-ICUD: Epidemiology of Prostate Cancer. Société Internationale d’Urologie Journal, 6(3), 44. https://doi.org/10.3390/siuj6030044
Vancouver
Melão BVLA, Pekala KR, Matsoukas K, Bratt O, Carlsson SV. SIU-ICUD: Epidemiology of Prostate Cancer. Société Internationale d’Urologie Journal. 2025;6(3):44. doi:10.3390/siuj6030044
BibTeX
@article{Melo2025,
author = {Melão, Bárbara Vieira Lima Aguiar and Pekala, Kelly R. and Matsoukas, Konstantina and Bratt, Ola and Carlsson, Sigrid V.},
title = {SIU-ICUD: Epidemiology of Prostate Cancer},
journal = {Société Internationale d’Urologie Journal},
year = {2025},
volume = {6},
number = {3},
pages = {44},
doi = {10.3390/siuj6030044}
}
EUVIMED